Dog Eczema Emulsie voor cutaan gebruik
Dog Eczema Emulsie voor cutaan gebruik
Authorised
- Zinc oxide
- PRECIPITATED SULPHUR
- Prednisolone
- NEOMYCIN SULFATE
Product identification
Medicine name:
Dog Eczema Emulsie voor cutaan gebruik
Active substance:
- Zinc oxide
- PRECIPITATED SULPHUR
- Prednisolone
- NEOMYCIN SULFATE
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Zinc oxide30.00/milligram(s)1.00gram(s)
-
PRECIPITATED SULPHUR5.00/milligram(s)1.00gram(s)
-
Prednisolone1.00/milligram(s)1.00gram(s)
-
NEOMYCIN SULFATE5000.00/international unit(s)1.00gram(s)
Pharmaceutical form:
-
Cutaneous emulsion
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07CA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Dog Eczema 500 g Bottle Cutaneous emulsion
- Dog Eczema 100 g Bottle Cutaneous emulsion
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Base Pharmaceuticals B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V097377
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
